StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Bluejay Diagnostics total assets

Total assets on the balance sheet at the end of each period.

Bluejay Diagnostics's total assets was $11.53M at Jun 30, 2026. For fiscal 2025 it was $7.12M, up 6.9% from the year before. The highest annual figure on record is $21.02M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.12M+6.9%
FY2024Dec 31, 2024$6.66M+36.7%
FY2023Dec 31, 2023$4.87M-64.0%
FY2022Dec 31, 2022$13.52M-35.7%
FY2021Dec 31, 2021$21.02M+1285.3%
FY2020Dec 31, 2020$1.52M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.53M+80.1%
Q1 FY2026Mar 31, 2026$5.60M+6.1%
Q4 FY2025Dec 31, 2025$7.12M+6.9%
Q3 FY2025Sep 30, 2025$4.89M-41.5%
Q2 FY2025Jun 30, 2025$6.40M-41.0%
Q1 FY2025Mar 31, 2025$5.28M+4.0%
Q4 FY2024Dec 31, 2024$6.66M+36.7%
Q3 FY2024Sep 30, 2024$8.35M+1.3%
Q2 FY2024Jun 30, 2024$10.86M+28.1%
Q1 FY2024Mar 31, 2024$5.08M-53.4%
Q4 FY2023Dec 31, 2023$4.87M-64.0%
Q3 FY2023Sep 30, 2023$8.25M-47.5%
Q2 FY2023Jun 30, 2023$8.48M-53.1%
Q1 FY2023Mar 31, 2023$10.89M-45.8%
Q4 FY2022Dec 31, 2022$13.52M-35.7%
Q3 FY2022Sep 30, 2022$15.71M+333.5%
Q2 FY2022Jun 30, 2022$18.07M+1090.7%
Q1 FY2022Mar 31, 2022$20.08M–
Q4 FY2021Dec 31, 2021$21.02M–
Q3 FY2021Sep 30, 2021$3.62M–
Q4 FY2020Dec 31, 2020$1.52M–

More Bluejay Diagnostics figures

See a number that looks wrong?